1056 related articles for article (PubMed ID: 36906534)
1. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.
Yuan Z; Li Y; Zhang S; Wang X; Dou H; Yu X; Zhang Z; Yang S; Xiao M
Mol Cancer; 2023 Mar; 22(1):48. PubMed ID: 36906534
[TBL] [Abstract][Full Text] [Related]
2. Consequences of Extracellular Matrix Remodeling in Headway and Metastasis of Cancer along with Novel Immunotherapies: A Great Promise for Future Endeavor.
Ray SK; Mukherjee S
Anticancer Agents Med Chem; 2022; 22(7):1257-1271. PubMed ID: 34254930
[TBL] [Abstract][Full Text] [Related]
3. Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix.
Flies DB; Langermann S; Jensen C; Karsdal MA; Willumsen N
Front Immunol; 2023; 14():1199513. PubMed ID: 37662958
[TBL] [Abstract][Full Text] [Related]
4. Proinvasive extracellular matrix remodeling for tumor progression.
Kaushik N; Kim S; Suh Y; Lee SJ
Arch Pharm Res; 2019 Jan; 42(1):40-47. PubMed ID: 30515725
[TBL] [Abstract][Full Text] [Related]
5. Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment.
Marozzi M; Parnigoni A; Negri A; Viola M; Vigetti D; Passi A; Karousou E; Rizzi F
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360868
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix remodeling in the tumor immunity.
Du W; Xia X; Hu F; Yu J
Front Immunol; 2023; 14():1340634. PubMed ID: 38332915
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment.
Lv D; Fei Y; Chen H; Wang J; Han W; Cui B; Feng Y; Zhang P; Chen J
Front Immunol; 2024; 15():1340702. PubMed ID: 38690275
[TBL] [Abstract][Full Text] [Related]
8. The extracellular matrix in tumor progression and metastasis.
Eble JA; Niland S
Clin Exp Metastasis; 2019 Jun; 36(3):171-198. PubMed ID: 30972526
[TBL] [Abstract][Full Text] [Related]
9. Redox signaling-mediated tumor extracellular matrix remodeling: pleiotropic regulatory mechanisms.
Liu G; Li B; Qin S; Nice EC; Yang J; Yang L; Huang C
Cell Oncol (Dordr); 2024 Apr; 47(2):429-445. PubMed ID: 37792154
[TBL] [Abstract][Full Text] [Related]
10. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy.
Jiang Y; Zhang H; Wang J; Liu Y; Luo T; Hua H
J Hematol Oncol; 2022 Mar; 15(1):34. PubMed ID: 35331296
[TBL] [Abstract][Full Text] [Related]
11. Immune Modulatory Properties of Collagen in Cancer.
Rømer AMA; Thorseth ML; Madsen DH
Front Immunol; 2021; 12():791453. PubMed ID: 34956223
[TBL] [Abstract][Full Text] [Related]
12. Emerging roles of ECM remodeling processes in cancer.
Mohan V; Das A; Sagi I
Semin Cancer Biol; 2020 May; 62():192-200. PubMed ID: 31518697
[TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
Najafi M; Farhood B; Mortezaee K
J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449
[TBL] [Abstract][Full Text] [Related]
14. The regulatory roles of T helper cells in distinct extracellular matrix characterization in breast cancer.
Tian Q; Gao H; Ma Y; Zhu L; Zhou Y; Shen Y; Wang B
Front Immunol; 2022; 13():871742. PubMed ID: 36159822
[TBL] [Abstract][Full Text] [Related]
15. Biomechanical and biochemical remodeling of stromal extracellular matrix in cancer.
Malik R; Lelkes PI; Cukierman E
Trends Biotechnol; 2015 Apr; 33(4):230-6. PubMed ID: 25708906
[TBL] [Abstract][Full Text] [Related]
16. Rho-ROCK signaling regulates tumor-microenvironment interactions.
Johan MZ; Samuel MS
Biochem Soc Trans; 2019 Feb; 47(1):101-108. PubMed ID: 30559270
[TBL] [Abstract][Full Text] [Related]
17. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy.
Mai Z; Lin Y; Lin P; Zhao X; Cui L
Cell Death Dis; 2024 May; 15(5):307. PubMed ID: 38693104
[TBL] [Abstract][Full Text] [Related]
18. Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment.
Niland S; Eble JA
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379400
[TBL] [Abstract][Full Text] [Related]
19. Breaking Physical Barrier of Fibrotic Breast Cancer for Photodynamic Immunotherapy by Remodeling Tumor Extracellular Matrix and Reprogramming Cancer-Associated Fibroblasts.
Qiu ZW; Zhong YT; Lu ZM; Yan N; Kong RJ; Huang JQ; Li ZF; Nie JM; Li R; Cheng H
ACS Nano; 2024 Apr; 18(13):9713-9735. PubMed ID: 38507590
[TBL] [Abstract][Full Text] [Related]
20. The good and bad of targeting cancer-associated extracellular matrix.
Sangaletti S; Chiodoni C; Tripodo C; Colombo MP
Curr Opin Pharmacol; 2017 Aug; 35():75-82. PubMed ID: 28734136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
